Alzamend Neuro Announces Initiation of PI First-in-Human Clinical Trial of AL001
13 Sep 2021 //
BUSINESSWIRE
Alzamend Neuro and Altasciences to conduct a Phase I study for AL001.
17 Aug 2021 //
BUSINESSWIRE
13 Sep 2021 //
BUSINESSWIRE
17 Aug 2021 //
BUSINESSWIRE